Education
About Us
Working with TipRanks
Follow Us
Plus Therapeutics (PSTV)
NASDAQ:PSTV
186Rnl
Leptomeningeal Metastasis
Phase I
Recruiting
Multiple Dose Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases
Jul 02, 2025
―
Rhenium-186 Nanoliposome
Ependymoma, High Grade Gliomas
Phase I
Not Yet Recruiting
Determine Maximum Tolerated Dose, Safety, and Tolerability of Rhenium (186Re) in Pediatric Recurrent, Refractory or Progressive Ependymoma and High-Grade Glioma
May 03, 2025
―
Retreatment Rhenium Liposome
Glioma
Phase I
Recruiting
Safety & Efficacy/Tolerability of Rhenium-186 NanoLiposomes (186RNL) for Patients Who Received a Prior 186RNL Treatment
Jun 13, 2022
―
186Rnl
Leptomeningeal Metastasis
Phase I
Active Not Recruiting
Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases
Aug 23, 2021
―
Rhenium Liposome Treatment
Glioma
Phase I/II
Recruiting
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
Jan 11, 2012
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Plus Therapeutics (PSTV) have in its pipeline
PSTV is currently developing the following drugs: 186Rnl, Rhenium-186 Nanoliposome, Retreatment Rhenium Liposome. These drug candidates are in various stages of clinical development as the company works toward FDA approval.